Insights from 2023 ASCO® Annual Meeting

 

Insights from 2023 ASCO® Annual Meeting
Y

ASCO® 2023 Insights: "A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609 - The Vulvar Cancers"

By Insights from 2023 ASCO® Annual Meeting FEATURING Young Chae
By Insights from 2023 ASCO® Annual Meeting FEATURING Young Chae
162 views
June 8, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh

Featured Video

20:14
Exelixis

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem
GYN
08:10

Initial Efficacy & Safety Results From a Phase 2 ENGOT-ov60/GOG-3052…

Insights from 2023 ASCO® Annual Meeting

S. Banerjee

110 views
12:42

ASCO® 2023 Insights: "RUBY Trial - PROs in Primary Advanced or Recur…

Insights from 2023 ASCO® Annual Meeting

M. Raza Mirza

194 views
07:24

ASCO® 2023 Insights: "BRCA1 and RAD51 Methylation Impact on Outcome …

Insights from 2023 ASCO® Annual Meeting

H. Blons

143 views
06:29

ASCO® 2023 Insights: "TEDOVA Trial - Neo-Epitope Based Vaccine Alone…

Insights from 2023 ASCO® Annual Meeting

A. Leary

380 views
09:28

ASCO® 2023 Insights: "A Phase II Basket Trial of Dual Anti-CTLA-4 an…

Insights from 2023 ASCO® Annual Meeting

Y. Chae

162 views